Pharma Related News
Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk
Researchers have made a significant breakthrough in the development of an intranasal COVID-19 vaccine.
Scientists from Lancaster University have carried out pre-clinical trials of a...
Cholesterol drug could reduce SARS-CoV-2 infection by up to 70%
Scientists have identified a licensed drug that they say could significantly reduce the risk of COVID-19 infection.
An international study, led by the University of...
Defence Therapeutics partners with pharmaceutical experts
Biotechnology company Defence Therapeutics has partnered with a pharmaceutical consultancy to maximise the potential of its developments.
In a bid to strengthen its development of...
Existing drugs could prevent blood clots in severe COVID-19 cases
New findings that COVID-19-related blood clots may be caused by an abnormal antibody response could help to identify preventative treatments.
Researchers have demonstrated how antibodies...
Longer interval between Pfizer vaccine doses boosts antibody protection
A longer dosing schedule for the Pfizer COVID-19 vaccine triggered the most effective immune response, new research has found.
A new and extensive pre-print study...
Modifying the immune system could enhance vaccine efficacy
Vaccine efficacy could be enhanced using new insights about the immune system, researchers say.
Immunologists at St. Jude Children's Research Hospital have discovered a biological...
AI technology identifies 160 possible new drug treatments for COVID-19
Scientists have discovered a total of 200 approved drugs that could treat COVID-19, but only 40 are currently being tested in clinical trials.
Researchers from...
CoronaVac COVID-19 vaccine safe for children as young as three
A clinical trial has proven that the CoronaVac COVID-19 vaccine is safe for children and adolescents aged between three to 17.
The CoronaVac vaccine, which...
Defence Therapeutics: Transforming drug delivery and improving treatment
Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious...
App aids safe prescribing of COVID-19 treatment drugs
A new mobile app has been launched to advise on the safe prescribing of experimental drugs for the treatment of COVID-19.
The University of Liverpool...
Towards a cancer revolution with new targeted therapeutics
Defence Therapeutics Inc’s proprietary new platform offers a revolution in drug delivery.
Quebec-based biotechnology developer Defence Therapeutics Inc specialises in antibody-drug conjugates (ADCs), a novel...
XPhyto: Is mescaline the next big mood-modifying medicine?
Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
Those with prior COVID-19 infection have boosted immune response
A new study has shown that people who have previously contracted COVID-19 have significantly higher T cell and antibody responses following a single dose...
Two trials for COVID-19 treatments launched in the UK
The UK has launched two trials that will test the efficacy of treatments which prevent people from catching COVID-19.
The PROTECT-V trial, run by the...
Oxford vaccine data suggests it reduces COVID-19 transmission
New data on the Oxford/AstraZeneca vaccine has suggested that it may have a substantial impact on transmission of COVID-19.
Analyses of PCR positive swabs from...
Global Ebola vaccine stockpile now established
A global stockpile of Ebola vaccines has now been established by four of the leading health and humanitarian organisations.
Led by the International Coordinating Group...
Moderna COVID-19 vaccine receives approval in UK
The British Government has now authorised the Moderna COVID-19 vaccine for use.
The Moderna COVID-19 vaccine has become the third in Britain to gain authorisation...
COVID-19 immunity could last eight months, says research
New research has suggested that immunity to COVID-19 could last for up to eight months following infection.
The findings, which were based on blood samples...
Lifesaving COVID-19 treatments for NHS patients
Patients in intensive care units across the UK will be receiving potentially lifesaving treatments for COVID-19.
The government-funded REMAP-CAP clinical trial has shown that the...
WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use
As more countries across the globe begin rolling out their mass COVID-19 vaccination programmes, the World Health Organization (WHO) has now listed the Pfizer/BioNTech...
